The scientist’s investigation covers issues in Molecular biology, Clostridium botulinum, Biochemistry, Neurotoxin and Synaptotagmin 1. His Molecular biology study integrates concerns from other disciplines, such as Clostridium botulinum type B, Ganglioside binding, Cell biology, Exoenzyme and Membrane protein. His Clostridium botulinum study is related to the wider topic of Toxin.
His work on Receptor as part of general Biochemistry research is frequently linked to Microglia, bridging the gap between disciplines. His work deals with themes such as Ganglioside, Binding site and Clostridium botulinum type A, which intersect with Neurotoxin. His Synaptotagmin 1 research incorporates elements of Biophysics, STX1A and Voltage-dependent calcium channel.
Shunji Kozaki mainly investigates Clostridium botulinum, Molecular biology, Microbiology, Biochemistry and Toxin. His Clostridium botulinum research integrates issues from Botulism, Neurotoxin and Clostridiaceae. His Molecular biology course of study focuses on Monoclonal antibody and Epitope and Immunoglobulin light chain.
His Microbiology research includes themes of Titer, Antibody, Gene and Virology. His Biochemistry research is multidisciplinary, incorporating elements of Biophysics and Nitric oxide. In his research, Pharmacology is intimately related to Botulinum toxin, which falls under the overarching field of Toxin.
Virology, Botulism, Botulinum toxin, Clostridium botulinum and Neurotoxin are his primary areas of study. His Virology research is multidisciplinary, incorporating perspectives in In vivo, Microbiology and Polyclonal antibodies. In general Microbiology, his work in Clostridium botulinum type B is often linked to Strain linking many areas of study.
In his study, Ganglioside, Immunoglobulin light chain, Recombinant DNA, Antigenicity and Binding site is inextricably linked to Molecular biology, which falls within the broad field of Clostridium botulinum. His study in Neurotoxin is interdisciplinary in nature, drawing from both Axoplasmic transport, Neuroscience, Epilepsy, Biological activity and Pharmacology. His Toxin study improves the overall literature in Biochemistry.
His main research concerns Neurotoxin, Toxin, Pharmacology, Biochemistry and Clostridium botulinum. His Neurotoxin study combines topics in areas such as Tetrodotoxin, Axoplasmic transport, Neuroscience, Ganglioside and Ganglioside binding. His biological study spans a wide range of topics, including Botulinum toxin and Grip strength.
His work carried out in the field of Pharmacology brings together such families of science as Glutamate receptor, Secretion, Contraction and Ganglion. His studies deal with areas such as Molecular biology, Botulism, Gene and Vaccination as well as Clostridium botulinum. A large part of his Molecular biology studies is devoted to Gel electrophoresis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
Tomonori Nochi;Yoshikazu Yuki;Haruko Takahashi;Shin Ichi Sawada.
Nature Materials (2010)
An extensive outbreak of staphylococcal food poisoning due to low-fat milk in Japan: estimation of enterotoxin A in the incriminated milk and powdered skim milk.
T Asao;Y Kumeda;T Kawai;T Shibata.
Epidemiology and Infection (2003)
Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes.
Tei Ichi Nishiki;Yoichi Kamata;Yasuo Nemoto;Akira Omori.
Journal of Biological Chemistry (1994)
Phosphorylation of 25-kDa Synaptosome-associated Protein POSSIBLE INVOLVEMENT IN PROTEIN KINASE C-MEDIATED REGULATION OF NEUROTRANSMITTER RELEASE
Youji Shimazaki;Tei Ichi Nishiki;Akira Omori;Mariko Sekiguchi.
Journal of Biological Chemistry (1996)
The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a
Tei Ichi Nishiki;Yoshimi Tokuyama;Yoichi Kamata;Yasuo Nemoto.
FEBS Letters (1996)
ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle
Masamitsu Yamamoto;Nobuyuki Marui;Toshiyuki Sakai;Narito Morii.
Oncogene (1993)
A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses.
Tomonori Nochi;Yoshikazu Yuki;Akiko Matsumura;Mio Mejima.
Journal of Experimental Medicine (2007)
Purification and some properties of Aeromonas hydrophila hemolysin.
T Asao;Y Kinoshita;S Kozaki;T Uemura.
Infection and Immunity (1984)
Interaction of SNARE Complexes with P/Q-type Calcium Channels in Rat Cerebellar Synaptosomes
Nicole Martin-Moutot;Nathalie Charvin;Christian Leveque;Kazuki Sato.
Journal of Biological Chemistry (1996)
ADP-ribosylation of the rho/rac proteins induces growth inhibition, neurite outgrowth and acetylcholine esterase in cultured PC-12 cells.
Teiichi Nishiki;Shuh Narumiya;Narito Morii;Masamitsu Yamamoto.
Biochemical and Biophysical Research Communications (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Tokyo
Kitasato University
Kyoto University
Hamamatsu Photonics (Japan)
Hokkaido University
Osaka Metropolitan University
Duke University
Hanover University of Applied Sciences and Arts
University of Alabama at Birmingham
Kyoto University
University of California, Irvine
Shanghai Jiao Tong University
University of Pennsylvania
Universidade de São Paulo
University of Massachusetts Boston
Max Planck Society
Gakushuin University
Vita-Salute San Raffaele University
University of Tasmania
Harvard University
Stony Brook University
York University
University of Bergen
Menarini Biomarkers Singapore
Mayo Clinic
Emory University